References
- Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 1993; 13:2031-40; PMID:8455596; http://dx.doi.org/10.1128/MCB.13.4.2031
- Loffing J, Flores SY, Staub O. SGK kinases and their role in epithelial transport. Annu Rev Physiol 2006; 68:461-90; PMID:16460280; http://dx.doi.org/10.1146/annurev.physiol.68.040104.131654
- Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 2008; 416:375-85; PMID:18925875; http://dx.doi.org/10.1042/BJ20081668
- Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P, Kim SY, et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 2009; 16:21-32; PMID:19573809; http://dx.doi.org/10.1016/j.ccr.2009.04.012
- Sommer EM, Dry H, Cross D, Guichard S, Davies BR, Alessi DR. Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors. Biochem J 2013; 452:499-508; PMID:23581296; http://dx.doi.org/10.1042/BJ20130342
- Castel P, Ellis H, Bago R, Toska E, Razavi P, Carmona FJ, Kannan S, Verma CS, Dickler M, Chandarlapaty S, Brogi E, et al. PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition. Cancer Cell 2016; 30:229-42; PMID:27451907; http://dx.doi.org/10.1016/j.ccell.2016.06.004
- Bago R, Sommer E, Castel P, Crafter C, Bailey FP, Shpiro N, Baselga J, Cross D, Eyers PA, Alessi DR. The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth. EMBO J 2016; 35(17):1902-22; PMID: 27481935; http://dx.doi.org/10.15252/embj.201693929